These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25042003)

  • 1. In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrP(C) to PrP(Sc).
    Pagadala NS; Perez-Pineiro R; Wishart DS; Tuszynski JA
    Eur J Med Chem; 2015 Feb; 91():118-31. PubMed ID: 25042003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
    Pagadala NS; Bjorndahl TC; Joyce M; Wishart DS; Syed K; Landi A
    Bioorg Med Chem; 2017 Oct; 25(20):5875-5888. PubMed ID: 28951092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches.
    Hyeon JW; Choi J; Kim SY; Govindaraj RG; Jam Hwang K; Lee YS; An SS; Lee MK; Joung JY; No KT; Lee J
    Sci Rep; 2015 Oct; 5():14944. PubMed ID: 26449325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico strategies on prion pathogenic conversion and inhibition from PrP
    Pagadala NS; Syed K; Bhat R
    Expert Opin Drug Discov; 2017 Mar; 12(3):241-248. PubMed ID: 28118747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Dynamics Simulation Study on the Binding and Stabilization Mechanism of Antiprion Compounds to the "Hot Spot" Region of PrP
    Zhou S; Liu X; An X; Yao X; Liu H
    ACS Chem Neurosci; 2017 Nov; 8(11):2446-2456. PubMed ID: 28795797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the structure determinants of pyrazinone derivatives as PDE5 3HC8 inhibitors: an in silico analysis.
    Li Y; Wu W; Ren H; Wang J; Zhang S; Li G; Yang L
    J Mol Graph Model; 2012 Sep; 38():112-22. PubMed ID: 23085160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods.
    Li L; Wei W; Jia WJ; Zhu Y; Zhang Y; Chen JH; Tian J; Liu H; He YX; Yao X
    J Comput Aided Mol Des; 2017 Dec; 31(12):1053-1062. PubMed ID: 29159521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.
    Vyas VK; Ghate M
    SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural investigation of PAP derivatives by CoMFA and CoMSIA reveals novel insight towards inhibition of Bcr-Abl oncoprotein.
    San Juan AA
    J Mol Graph Model; 2007 Sep; 26(2):482-93. PubMed ID: 17446106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
    Touil F; Pratt S; Mutter R; Chen B
    J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
    Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
    Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel fluorescent probes preventing PrP
    Zaccagnini L; Brogi S; Brindisi M; Gemma S; Chemi G; Legname G; Campiani G; Butini S
    Eur J Med Chem; 2017 Feb; 127():859-873. PubMed ID: 27842893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis.
    Wu Q; Gao Q; Guo H; Li D; Wang J; Gao W; Han C; Li Y; Yang L
    Mol Biosyst; 2013 Mar; 9(3):386-97. PubMed ID: 23354020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.